A local company is helping to target cancer at its roots by using cutting edge technology.
Hotel-Dieu Grace Healthcare houses the technology that comes from a molecular diagnostic company identifying specific mutations in the DNA extracted from individual cancer biopsies.
The ultimate goal is to identify mutations of our key genes and use treatments that are targeted and personalized.
Hotel-Dieu Grace says the million-dollar technology is the only one of its kind from here to London.
A news conference will be held at Hotel-Dieu Grace Wednesday morning to explain what this research means for cancer patients in Windsor-Essex and the future of cancer research.
